Luminus Management’s Minerva Surgical UTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-49,933
Closed -$794K – 32
2022
Q3
$794K Buy
49,933
+15,841
+46% +$600K 0.28% 21
2022
Q2
$1.6M Buy
34,092
+6,893
+25% +$399K 0.49% 18
2022
Q1
$2.45M Sell
27,199
-32,310
-54% -$3.28M 0.55% 13
2021
Q4
$6.12M Buy
+59,509
New +$8.46M 1.44% 16

Other funds holding UTRS

Luminus Management's UTRS Position: Q4 2022 in Review

Luminus Management sold out of Minerva Surgical (UTRS) in Q4 2022, closing a stake of 49,933 shares — an estimated $794K sold.

Luminus Management first reported a position in UTRS in Q4 2021 and held it in 4 quarters. The position peaked at $6.12M in Q4 2021. 20 funds tracked by Wall St. Rank hold UTRS as of Q4 2022.

  • Luminus Management reported no remaining Minerva Surgical position as of Q4 2022 after selling out during the quarter.
  • Luminus Management sold 49,933 Minerva Surgical shares in Q4 2022, an estimated $794K.
  • Luminus Management first reported a position in Minerva Surgical in Q4 2021 and held it in 4 quarters.
  • Luminus Management's Minerva Surgical position peaked at $6.12M in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Minerva Surgical as of Q4 2022.

Based on Luminus Management's 13F filing for Q4 2022, filed 14 Feb 2023.